Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment

In the post-genomic era, genetics has led to limited clinical applications in the diagnosis and treatment of major depressive disorder (MDD). Variants in genes coding for cytochrome enzymes are included in guidelines for assisting in antidepressant choice and dosing, but there are no recommendations...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabbri, Chiara, Montgomery, Stuart, Lewis, Cathryn M., Serretti, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390499/
https://www.ncbi.nlm.nih.gov/pubmed/32084067
http://dx.doi.org/10.1097/YIC.0000000000000305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390499/
https://www.ncbi.nlm.nih.gov/pubmed/32084067
http://dx.doi.org/10.1097/YIC.0000000000000305

Ejemplares similares